The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services. 

The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17. 

Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.

Melissa Hubbard says her gynecologist and surgeon decided to remove her ovaries during a colectomy but failed to inform her of their intent. The case’s fate is now in the hands of the Wisconsin Supreme Court. 

The agencies said private equity firms are rolling up healthcare sectors through serialized purchases that fly under the radar of regulators, creating an unsustainable level of consolidation. 

A new report from the Office of the Inspector General found the FDA failed to properly record meetings with drug manufacturers, ultimately approving drugs later shown to have safety and efficacy issues. 

The integration was announced during the annual JP Morgan Health Care Conference in San Francisco. The program works through Amazon Benefits Manager to remotely help patients with weight and blood pressure management.